Alopecia – Pipeline Review, H2 2019

“Global Markets Direct’s, ‘Alopecia – Pipeline Review, H2 2019’, provides an overview of the Alopecia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Alopecia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.”

Scope


– The report provides a snapshot of the global therapeutic landscape of Alopecia

– The report reviews pipeline therapeutics for Alopecia by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved Alopecia therapeutics and enlists all their major and minor projects

– The report assesses Alopecia therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

– The report summarizes all the dormant and discontinued pipeline projects

– The report reviews latest news related to pipeline therapeutics for Alopecia”

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Alopecia

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Alopecia pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

Aclaris Therapeutics Inc

Allergan Plc

Almirall SA

Berg LLC

BiologicsMD Inc

BirchBioMed Inc

Brickell Biotech Inc

Cassiopea SpA

Concert Pharmaceuticals Inc

Dong-A Socio Holdings Co Ltd

Eli Lilly and Co

Energenesis Biomedical Co Ltd

Follica Inc

Histogen Inc

Japan Tobacco Inc

JW Pharmaceutical Corp

Kuhnil Pharmaceutical Co Ltd

Lee's Pharmaceutical Holdings Ltd

Nepsone ehf

OliX Pharmaceuticals Inc

Pfizer Inc

Phio Pharmaceuticals Corp

Portola Pharmaceuticals Inc

Quark Pharmaceuticals Inc

Samumed LLC

Suzhou Ribo Life Sciences Co Ltd

Taisho Pharmaceutical Holdings Co Ltd

Tigo GmbH

Table of Contents

Table of Contents

Introduction

Alopecia Overview

Alopecia Therapeutics Development

Alopecia Therapeutics Assessment

Alopecia Companies Involved in Therapeutics Development

Alopecia Drug Profiles

Alopecia Dormant Projects

Alopecia Discontinued Products

Alopecia Product Development Milestones

Appendix

List of Tables

List of Tables

Number of Products under Development for Alopecia, H1 2019

Number of Products under Development by Companies, H1 2019

Number of Products under Development by Universities/Institutes, H1 2019

Products under Development by Companies, H1 2019

Products under Development by Universities/Institutes, H1 2019

Number of Products by Stage and Target, H1 2019

Number of Products by Stage and Mechanism of Action, H1 2019

Number of Products by Stage and Route of Administration, H1 2019

Number of Products by Stage and Molecule Type, H1 2019

Alopecia Pipeline by Aclaris Therapeutics Inc, H1 2019

Alopecia Pipeline by Allergan Plc, H1 2019

Alopecia Pipeline by Almirall SA, H1 2019

Alopecia Pipeline by Berg LLC, H1 2019

Alopecia Pipeline by BiologicsMD Inc, H1 2019

Alopecia Pipeline by BirchBioMed Inc, H1 2019

Alopecia Pipeline by Brickell Biotech Inc, H1 2019

Alopecia Pipeline by Cassiopea SpA, H1 2019

Alopecia Pipeline by Concert Pharmaceuticals Inc, H1 2019

Alopecia Pipeline by Dong-A Socio Holdings Co Ltd, H1 2019

Alopecia Pipeline by Eli Lilly and Co, H1 2019

Alopecia Pipeline by Energenesis Biomedical Co Ltd, H1 2019

Alopecia Pipeline by Follica Inc, H1 2019

Alopecia Pipeline by Histogen Inc, H1 2019

Alopecia Pipeline by Japan Tobacco Inc, H1 2019

Alopecia Pipeline by JW Pharmaceutical Corp, H1 2019

Alopecia Pipeline by Kuhnil Pharmaceutical Co Ltd, H1 2019

Alopecia Pipeline by Lee's Pharmaceutical Holdings Ltd, H1 2019

Alopecia Pipeline by Nepsone ehf, H1 2019

Alopecia Pipeline by OliX Pharmaceuticals Inc, H1 2019

Alopecia Pipeline by Pfizer Inc, H1 2019

Alopecia Pipeline by Phio Pharmaceuticals Corp, H1 2019

Alopecia Pipeline by Portola Pharmaceuticals Inc, H1 2019

Alopecia Pipeline by Quark Pharmaceuticals Inc, H1 2019

Alopecia Pipeline by Samumed LLC, H1 2019

Alopecia Pipeline by Suzhou Ribo Life Sciences Co Ltd, H1 2019

Alopecia Pipeline by Taisho Pharmaceutical Holdings Co Ltd, H1 2019

Alopecia Pipeline by Tigo GmbH, H1 2019

Alopecia Dormant Projects, H1 2019

Alopecia Discontinued Products, H1 2019

List of Figures

List of Figures

Number of Products under Development for Alopecia, H1 2019

Number of Products under Development by Companies, H1 2019

Number of Products by Top 10 Targets, H1 2019

Number of Products by Stage and Top 10 Targets, H1 2019

Number of Products by Top 10 Mechanism of Actions, H1 2019

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019

Number of Products by Routes of Administration, H1 2019

Number of Products by Stage and Routes of Administration, H1 2019

Number of Products by Molecule Types, H1 2019

Number of Products by Stage and Molecule Types, H1 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports